Tag: ASH 2015

trials-data-sharing_650x450
January 28, 2016/Research

Common Eligibility Criteria in Randomized Clinical Trials of Hematologic Malignancies May Be Too Stringent

Study suggests re-examining eligibility criteria for randomized controlled trials of hematologic malignancies.

ASHbanner_690x380
January 18, 2016/Research

The 10 Most Compelling Abstracts from ASH 2015

Takeaways from Cleveland Clinic’s hematology/medical oncology experts

ASHbanner_690x380
December 7, 2015/Blood Cancers

New Model Improves Prognostication for MDS and CMML Patients

Molecular data enhance traditional scoring systems

ASHbanner_690x380
December 7, 2015/Blood Cancers

Rational Treatment Modifications to Extend Responses to 5-Azacytidine and Decitabine

Research improving myelodysplastic syndromes treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

ASHbanner_690x380
December 7, 2015/Blood Cancers

Radioactive Iodine Treatment of Thyroid Cancers Increases Risk of MDS

Cleveland Clinic researchers warn against overtreatment

ASHbanner_690x380
December 7, 2015/Blood Cancers

Standard-of-Care Treatment Often Ignored for Cancer-Associated Thrombosis

Insurance data analysis uncovers real-world behaviors

ASHbanner_690x380
December 6, 2015/Blood Cancers

Expanding Clones Seen in Minority of Patients With Aplastic Anemia Treated With Eltrombopag

Researchers suspect that mutations may be leukemogenic

BackPage 1 of 1Next
Advertisement
Ad